Founded in 2016, Onco operates in Health Tech industry. Initially focused on connecting cancer patients with expert oncologists for personalized treatment plans, the company has broadened its approach...
Funding stage:
Debt Financing
Last funding:
01/12/2020
Total funding:
$8.22 Mn+
Revenue:
Investors
Employee count:
289
Last 90d
289
Last 90d
Web traffic:
9.38K
9.38K
Last 30d
Last 30d
Glassdoor Rating:
Onco: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders42
Latest Filing Date26 April 2022- Funding Events10
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Onco
As of 27 April 2022, Onco's equity is held by 41 shareholders, with the top three being Rashie Jain, Accel India V Mauritius Limited, and Amit K Jotwani.
Rashie Jain holds the largest stake in Onco at 26.0% as of 27 April 2022.
As of 27 April 2022, founders collectively hold 43.5% equity in Onco.
As of 27 April 2022, investors collectively hold 49.8% equity in Onco.
Onco's ESOP pool stands at 6.7% of total equity as of 27 April 2022.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links